Alternate channel therapy for cystic fibrosis lung disease
L Delpiano - 2023 - theses.ncl.ac.uk
Cystic Fibrosis (CF) is the most common, severe, autosomal recessive disease in the
Caucasian population, and is caused by mutations in the cystic fibrosis transmembrane …
Caucasian population, and is caused by mutations in the cystic fibrosis transmembrane …
[HTML][HTML] Targeting ion channels in cystic fibrosis
MA Mall, LJV Galietta - Journal of Cystic Fibrosis, 2015 - Elsevier
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause a
characteristic defect in epithelial ion transport that plays a central role in the pathogenesis of …
characteristic defect in epithelial ion transport that plays a central role in the pathogenesis of …
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?
Introduction Cystic fibrosis (CF), a potentially fatal genetic disease, is caused by loss-of-
function mutations in the gene encoding for the CFTR chloride/bicarbonate channel …
function mutations in the gene encoding for the CFTR chloride/bicarbonate channel …
TMEM16A: An alternative approach to restoring airway anion secretion in cystic fibrosis?
H Danahay, M Gosling - International Journal of Molecular Sciences, 2020 - mdpi.com
The concept that increasing airway hydration leads to improvements in mucus clearance
and lung function in cystic fibrosis has been clinically validated with osmotic agents such as …
and lung function in cystic fibrosis has been clinically validated with osmotic agents such as …
[HTML][HTML] Ion channels as targets to treat cystic fibrosis lung disease
Lung health relies on effective mucociliary clearance and innate immune defence
mechanisms. In cystic fibrosis (CF), an imbalance in ion transport due to an absence of …
mechanisms. In cystic fibrosis (CF), an imbalance in ion transport due to an absence of …
Personalised therapies for all: Targeting alternative chloride channels in Cystic Fibrosis
MC Pinto - 2022 - repositorio.ul.pt
Cystic Fibrosis (CF) is a life-shortening genetic disorder caused by mutations in the CF
Transmembrane Conductance Regulator (CFTR) gene, which encodes a cAMP-regulated …
Transmembrane Conductance Regulator (CFTR) gene, which encodes a cAMP-regulated …
Pharmacological modulation of ion channels for the treatment of cystic fibrosis
MC Pinto, IAL Silva, MF Figueira… - Journal of …, 2021 - Taylor & Francis
Cystic fibrosis (CF) is a life-shortening monogenic disease caused by mutations in the gene
encoding the CF transmembrane conductance regulator (CFTR) protein, an anion channel …
encoding the CF transmembrane conductance regulator (CFTR) protein, an anion channel …
Pharmacological therapy for cystic fibrosis: from bench to bedside
With knowledge of the molecular behaviour of the cystic fibrosis transmembrane
conductance regulator (CFTR), its physiological role and dysfunction in cystic fibrosis (CF) …
conductance regulator (CFTR), its physiological role and dysfunction in cystic fibrosis (CF) …
Challenges facing airway epithelial cell-based therapy for cystic fibrosis
A Berical, RE Lee, SH Randell… - Frontiers in pharmacology, 2019 - frontiersin.org
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause
the life-limiting hereditary disease, cystic fibrosis (CF). Decreased or absent functional CFTR …
the life-limiting hereditary disease, cystic fibrosis (CF). Decreased or absent functional CFTR …